Fernando Jerkovich
Overview
Explore the profile of Fernando Jerkovich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jerkovich F, Capalbo S, Abelleira E, Pitoia F
Endocrine
. 2024 May;
85(2):817-826.
PMID: 38772990
Purpose: To evaluate objective response rates (ORR), progression-free survival (PFS), and overall survival (OS) associated with tyrosine kinase inhibitors (TKIs) in patients with radioiodine refractory differentiated thyroid cancer (RR-DTC). Additionally,...
2.
Farias V, Jerkovich F, Barragan A, Pereyra A, Gonzalez Pernas M, Abdala R, et al.
JBMR Plus
. 2024 May;
8(6):ziae044.
PMID: 38764789
Data on long-term treatment regimens for preventing bone mineral density (BMD) loss that occurs after denosumab (Dmab) withdrawal are scarce. Our aim was to evaluate the long-term changes (12-36 months)...
3.
Abelleira E, Jerkovich F
Rev Endocr Metab Disord
. 2023 Nov;
25(1):79-93.
PMID: 38015344
The current approach for patients with differentiated thyroid carcinoma should be individualized according to the risk of recurrence, and this stratification could be used to identify the risk of persistent/recurrent...
4.
Clifton Goldney D, Pelegrin C, Jerkovich F, Longobardi V, Rodriguez E, Zanchetta M
Osteoporos Int
. 2023 Sep;
35(1):165-171.
PMID: 37702746
Purpose: To describe the densitometric and biochemical changes achieved with osteoactive treatment after 24 months of follow-up in patients who suffered rebound-associated vertebral fractures (RAVFs) after Dmab discontinuation, and to...
5.
Califano I, Smulever A, Jerkovich F, Pitoia F
Rev Endocr Metab Disord
. 2023 Aug;
25(1):123-147.
PMID: 37648897
Anaplastic thyroid cancer (ATC) is an infrequent thyroid tumor that usually occurs in elderly patients. There is often a history of previous differentiated thyroid cancer suggesting a biological progression. It...
6.
Jerkovich F, Abelleira E, Bueno F, Guerrero L, Pitoia F
Thyroid
. 2022 Jul;
32(10):1178-1183.
PMID: 35876426
It has been suggested that small metastatic lymph nodes (LNs) detected after initial surgery in patients with differentiated thyroid cancer (DTC) can be managed with active surveillance (AS). However, there...
7.
Sarli M, Collaceli M, Jerkovich F, Rey P, Spivacow R, Zanchetta M
Medicina (B Aires)
. 2022 May;
82(3):408-414.
PMID: 35639062
The epidemiology of Paget's disease of bone (PDB) has changed in the last years but there is no update data on its clinical presentation, diagnosis and management in Latin America....
8.
Abdala R, Mana D, Gonzales Pernas M, Dalto J, Sesta M, Jerkovich F, et al.
J Clin Densitom
. 2022 May;
25(4):587-591.
PMID: 35606280
The assessment of regional bone mineral density (BMD) has proved to be useful for illustrating the impact of focal bone demineralization diseases on bone mass. In these scenario, a common...
9.
Pitoia F, Jerkovich F, Trimboli P, Smulever A
World J Clin Oncol
. 2022 Feb;
13(1):9-27.
PMID: 35116229
The cumulative evidence over the past decades has shown that the incidence of differentiated thyroid carcinoma (DTC) has exponentially increased. Approximately 10% of patients with DTC exhibit recurrent or metastatic...
10.
Abelleira E, Penaloza M, Jerkovich F, Bueno F, Pitoia F
Arch Endocrinol Metab
. 2021 Nov;
65(3):315-321.
PMID: 34731559
Objective: The treatment of patients with differentiated thyroid cancer (DTC) was modified in the last decade towards a more individualized approach according to the risk of recurrence (RR). We compared...